Infectious diseases: Coronavirus-Covid19 vaccine
One of the relevant features of BiOMViS’ technology is the rapidity with which OMV-based vaccine formulations can be produced and tested. Soon after the sequence and the 3D structure of …
Infectious diseases: Staphylococcus aureus vaccine
BiOMViS has tested the potential of its OMV-based platform technology to develop a vaccine against Staphylococcus aureus. S. aureus is a human pathogen responsible for community and hospital-acquired invasive diseases. …
Relevant publications
Michele Tomasi, Elena Caproni, Mattia Benedet, Ilaria Zanella, Sebastiano Giorgetta, Mattia Dalsass, Enrico König, Assunta Gagliardi, Laura Fantappiè, Alvise Berti, Silvia Tamburini, Lorenzo Croia, Gabriele Di Lascio, Erika Bellini, Silvia …
Personalized cancer vaccines
Tumors develop as a consequence of gene mutations that alter cellular morphology and metabolism. These mutations, that give tumors a selective growth advantage over healthy tissues, potentially represent tumors’ “Achilles’ …
BiOMViS Vaccine Platform
BiOMViS vaccine platform is based on Outer Membrane Vesicles (OMVs) released by a non-pathogenic E. coli derivative (E. coli BL21Δ60) created by a Synthetic Biology approach. The amazing properties of …